US Patent Issued to Gan & Lee Pharmaceuticals on March 17 for "Insulin derivative" (Chinese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,136, issued on March 17, was assigned to Gan & Lee Pharmaceuticals Co. Ltd. (Beijing).

"Insulin derivative" was invented by Zhongru Gan (Beijing), Wei Chen (Beijing), Yining Zhang (Beijing), Fangkai Xue (Beijing), Lingyu Cai (Beijing), Jianghong Niu (Beijing) and Bin Mu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an acylated insulin, a pharmaceutical formulation thereof, a pharmaceutical composition thereof with a long-acting GLP-1 compound, and a medical use of the acylated insulin, the pharmaceutical formulation and the pharmaceutical composition. Compared with insulin degludec or other insulin derivatives, the acylated i...